The company said it held its Annual Meeting of Shareholders on May 15, 2024. As of March 20, 2024, the record date, there were 424,775,912 shares of common stock outstanding and entitled to vote.

1. 01

   The company said it held its Annual Meeting of Shareholders on May 15, 2024. As of March 20, 2024, the record date, there were 424,775,912 shares of common stock outstanding and entitled to vote.

2. 02

   The company said shareholders elected 4 Class III directors, each to serve a 3-year term. Douglas T. Terreson received 288,129,833 votes for and 21,775,054 against, and Lisa A. Davis received 279,747,731 votes for and 30,209,350 against.

3. 03

   The company said shareholders approved, on an advisory basis, executive compensation with 288,566,492 votes for and 20,573,008 votes against. The ratification of Ernst & Young LLP as independent registered public accounting firm for 2024 was approved with 365,557,145 votes for and 4,253,214 votes against.

4. 04

   The company said a shareholder proposal requesting a report analyzing the impact of the System Change Scenario on the Chemicals business was not approved, with 36,181,887 votes for and 271,765,922 votes against.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.